Serum immunoglobulin A concentration is a reliable biomarker for liver fibrosis in non-alcoholic fatty liver disease

doi:10.3748/wjg.v20.i35.12566

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 35

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5621)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

499

WORD

233

HTML

3843

Figures (1-2)

126

Tables (1-3)

123

Sum=4824

Sep 21, 2014 (publication date) through Apr 19, 2024

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Control Study

World J Gastroenterol. Sep 21, 2014; 20(35): 12566-12573
Published online Sep 21, 2014. doi: 10.3748/wjg.v20.i35.12566

Open in New Tab Full Size Figure Download Figure

Figure 1 Serum Immunoglobulin A levels in different stages of fibrosis.

Open in New Tab Full Size Figure Download Figure

Figure 2 Receiver operating characteristic curves analysis of serum Immunoglobulin A and fibrosis (F0 vs F1-4). ROC: Receiver operating characteristic.

Citation: Maleki I, Aminafshari MR, Taghvaei T, Hosseini V, Rafiei A, Torabizadeh Z, Barzin M, Orang E. Serum immunoglobulin A concentration is a reliable biomarker for liver fibrosis in non-alcoholic fatty liver disease. World J Gastroenterol 2014; 20(35): 12566-12573
URL: https://www.wjgnet.com/1007-9327/full/v20/i35/12566.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i35.12566